Geographic variations as large as 47% for medical imaging have been identified in the first systematic study of its kind, performed by researchers at Thomas Jefferson University in Philadelphia. A comparison of changes in geographic utilization rates from 1997 to 2002 reveals that cardiologists have higher growth rates for Medicare-reimbursed imaging than radiologists or other physicians who perform medical imaging, said Dr. Vijay Rao, radiology director at Jefferson.
Geographic variations as large as 47% for medical imaging have been identified in the first systematic study of its kind, performed by researchers at Thomas Jefferson University in Philadelphia. A comparison of changes in geographic utilization rates from 1997 to 2002 reveals that cardiologists have higher growth rates for Medicare-reimbursed imaging than radiologists or other physicians who perform medical imaging, said Dr. Vijay Rao, radiology director at Jefferson.
"In all of the 10 regions of the country, the utilization growth rate is higher - in fact, it is much higher - among cardiologists compared to radiologists," she said.
Data were drawn from the Medicare Part B fee-for-service statistics for 1997 and 2002 for regions surrounding Atlanta, Boston, Chicago, Dallas, Denver, Kansas City, New York, Philadelphia, San Francisco, and Seattle.
Outpatient imaging utilization rates for Medicare beneficiaries in 2002 ranged from 3959 per thousand in Atlanta to a low of 2694 per thousand in Seattle.
The rates attributed to radiologists varied 39% across the country. They were highest in Philadelphia, where radiologists performed 2511 exams per 1000 population in 2002. They were lowest in San Francisco, where the utilization rate was 1803 per thousand.
In contrast, the utilization rates for imaging procedures performed by cardiologists varied by 91% from 323 to 617 per thousand from region to region, Rao said. For other physicians, the highs and lows were 941 and 568, respectively.
More analysis is needed to understand the reasons for regional variations in the use of diagnostic imaging, she said.
"We don't know why there is such a big variation. It could be access. It could relate to the amount of disease, or it could relate to the population," Rao said.
Can Portable Dual-Energy X-Ray be a Viable Alternative to CT in the ICU?
September 13th 2024The use of a portable dual-energy X-ray detector in the ICU at one community hospital reportedly facilitated a 37.5 percent decrease in chest CT exams in comparison to the previous three months, according to research presented at the American Society of Emergency Radiology (ASER) meeting in Washington, D.C.
New Meta-Analysis Examines MRI Assessment for Treatment of Esophageal Cancer
September 12th 2024Diffusion-weighted MRI provided pooled sensitivity and specificity rates of 82 percent and 81 percent respectively for gauging patient response to concurrent chemoradiotherapy for esophageal cancer, according to new meta-analysis.
Study for Emerging PET/CT Agent Reveals ‘New Standard’ for Detecting Clear Cell Renal Cell Carcinoma
September 11th 2024Results from a multicenter phase 3 trial showed that the PET/CT imaging agent (89Zr)Zr-girentuximab had an 85.5 percent mean sensitivity rate for the diagnosis of clear cell renal cell carcinoma.
Can Radiomics and Autoencoders Enhance Real-Time Ultrasound Detection of Breast Cancer?
September 10th 2024Developed with breast ultrasound data from nearly 1,200 women, a model with mixed radiomic and autoencoder features had a 90 percent AUC for diagnosing breast cancer, according to new research.